The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?

2026-01-292026-01-29201610.1080/14787210.2016.12434662-s2.0-84991503880https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27507Infectious DiseasesMicrobiologyMicrobiology (medical)VirologyThe risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?editorial